News

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few ...
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA ...
The FDA will make it more costly to seek approval of Covid-19 vaccines, but Moderna's shareholder reacted favorable to the ...
The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who ...
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...